Transcriptomics

Dataset Information

0

Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE51815 | GEO | 2014/08/01

SECONDARY ACCESSION(S): PRJNA225475

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer (methylation)
2014-08-01 | E-GEOD-51810 | biostudies-arrayexpress
Transcriptomics Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer
2014-08-01 | E-GEOD-51815 | biostudies-arrayexpress
Methylation profiling Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer (methylation)
2014-08-01 | GSE51810 | GEO
Transcriptomics Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer (gene expression)
2014-08-01 | E-GEOD-51811 | biostudies-arrayexpress
Transcriptomics Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer (gene expression)
2014-08-01 | GSE51811 | GEO
Unknown Gene body methylation can alter gene expression and is a therapeutic target in cancer.
| S-EPMC4224113 | biostudies-literature
Unknown ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
| S-EPMC7431863 | biostudies-literature
Unknown DNA Methylation as a Therapeutic Target for Bladder Cancer.
| S-EPMC7463638 | biostudies-literature
Unknown Identification of new octamer transcription factor 1-target genes upregulated in castration-resistant prostate cancer.
| S-EPMC6825001 | biostudies-literature
Unknown CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer.
| S-EPMC9250190 | biostudies-literature